文献速递神经肿瘤

多发病灶对脑膜瘤无进展生存期的影响:一项10年多中心经验

The impact of multiple lesions on progression-free survival of meningiomas: a 10-year multicenter experience.
PubMed 文献 · J Neurosurg · 2021-11-19

该研究回顾性分析2009年1月至2020年5月三个主要中心确诊的838例成人脑膜瘤患者,探讨病灶数目及临床特征对WHO I级脑膜瘤无进展生存期(PFS)的影响。多发病灶患者PFS和至第二次干预时间(TTSI)均显著短于单发病灶者,每增加一个病灶PFS和TTSI均显著变差。非洲裔美国患者PFS较非西班牙裔白人患者差,而年龄较大和辅助放疗与PFS改善相关。

要点

  • 多发病灶脑膜瘤患者PFS和TTSI均显著短于单发病灶患者。
  • 每增加一个脑膜瘤病灶,PFS和TTSI均显著变差。
  • 非洲裔美国患者PFS较非西班牙裔白人患者差。

核心结论

  • 脑膜瘤PFS似乎受病灶数目影响,多发病灶患者更易因疾病进展接受第二次干预,因此多发病灶患者可能需要更密切的随访。

研究设计与样本

  • 回顾性综述三个主要中心2009年1月至2020年5月确诊的所有成人脑膜瘤患者记录,共纳入838例。

主要发现

  • 多发病灶组与单发病灶组比较,PFS和TTSI的log-rank检验均显示多发病灶组进展显著更短(p < 0.001和p < 0.001)。
  • 多因素Cox回归分析显示,多发病灶组PFS显著劣于单发病灶组(HR 2.262,95%CI 1.392-3.677,p = 0.001),TTSI亦显著劣于单发病灶组(HR 2.377,95%CI 1.617-3.494,p = 0.001)。
  • 将脑膜瘤数目作为连续变量分析,每增加一个脑膜瘤PFS显著变差(HR 1.350,95%CI 1.074-1.698,p = 0.010),TTSI亦显著变差(HR 1.428,95%CI 1.189-1.716,p < 0.001)。
  • 非洲裔美国患者PFS较非西班牙裔白人患者差(HR 3.472,95%CI 1.083-11.129,p = 0.036)。
  • 年龄较大和辅助放疗与PFS改善相关。

临床怎么用

  • 作者认为,多发病灶患者可能需要更密切的随访。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Multiple meningiomas (MMs) occur in as many as 18% of patients with meningioma, and data on progression-free survival (PFS) are scarce. The objective of this study was to explore the influence of the number of lesions and clinical characteristics on PFS in patients with WHO grade I meningiomas. METHODS: The authors retrospectively reviewed the records of all adults diagnosed with a meningioma at their three main sites from January 2009 to May 2020. Progression was considered the time from diagnosis until radiographic growth of the originally resected meningioma. A secondary analysis was performed to evaluate the time of diagnosis until the time to second intervention (TTSI). Univariable and multivariable analyses were conducted to assess whether the number of lesions or any associated variables (age, sex, race, radiation treatment, tumor location, and extent of resection) had a significant impact on PFS and TTSI. RESULTS: Eight hundred thirty-eight patients were included. Use of a log-rank test to evaluate PFS and TTSI between a single and multiple lesions showed a significantly shorter progression for MM (p < 0.001 and p < 0.001, respectively). Multivariable Cox regression analysis showed significantly inferior PFS on MM compared to a single lesion (hazard ratio [HR] 2.262, 95% confidence interval [CI] 1.392-3.677, p = 0.001) and a significantly inferior TTSI for patients with MM when compared to patients with a single meningioma (HR 2.377, 95% CI 1.617-3.494, p = 0.001). By testing the number of meningiomas as a continuous variable, PFS was significantly inferior for each additional meningioma (HR 1.350, 95% CI 1.074-1.698, p = 0.010) and TTSI was significantly inferior as well (HR 1.428, 95% CI 1.189-1.716, p < 0.001). African American patients had an inferior PFS when compared to non-Hispanic White patients (HR 3.472, 95% CI 1.083-11.129, p = 0.036). CONCLUSIONS: The PFS of meningiomas appears to be influenced by the number of lesions present. Patients with MM also appear to be more prone to undergoing a second intervention for progressive disease. Hence, a closer follow-up may be warranted in patients who present with multiple lesions. These results show a decreased PFS for each additional lesion present, as well as a shorter PFS for MM compared to a single lesion. When assessing associated risk factors, African American patients showed an inferior PFS, whereas older age and adjuvant therapy with radiation showed an improved PFS.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ramos-Fresnedo A, Domingo RA, Sanchez-Garavito JE, et al. The impact of multiple lesions on progression-free survival of meningiomas: a 10-year multicenter experience. J Neurosurg. 2021. PMID: 34798603. doi:10.3171/2021.8.JNS211252

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。